Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)
Clinical trial NCT04498325 · WITHDRAWN
Trial details
- NCT number
- NCT04498325
- Sponsor
- Washington University School of Medicine
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2022-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.